Identification of novel inhibitors of P13K/AKT pathways: an integrated in-silico study towards the development of a new therapeutic agent against ovarian cancer
Sign Up to like & getrecommendations! Published in 2023 at "Physical Sciences Reviews"
DOI: 10.1515/psr-2022-0341
Abstract: Abstract Ovarian cancer is a crucial gynaecological unmet medical disease with a high mortality rate. According to recent research, the phosphoinositol 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathways are hyper-activated in… read more here.
Keywords: inhibitors p13k; ovarian cancer; kcal mol; p13k akt ... See more keywords